Priscilla S. Redd

1.7k citations

27 papers · 1.2k indexed · h-index 15

Impact in

Immunology top 5%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Oncology top 5%
- Cancer Immunotherapy and Biomarkers

Papers in

Immunology 19
- Immune cells in cancer 10
- Immune Cell Function and Interaction 8
- Immunotherapy and Immune Responses 4
- Immune Response and Inflammation 3
Oncology 14
- Cancer Immunotherapy and Biomarkers 11

Co-authors: Kebin Liu Chunwan Lu John D. Klement Dafeng Yang Mohammed L. Ibrahim Natasha M. Savage Amy V. Paschall Jeffrey R. Lee
Journals: The Journal of Immunology (3 papers)Cancer Research (3 papers)Cancers (2 papers)OncoImmunology (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)
Partner nations: United States Georgia Egypt

In The Last Decade

Priscilla S. Redd

26 papers receiving 1.2k citations

Peers

Countries citing papers authored by Priscilla S. Redd

Since Specialization

Citations

This map shows the geographic impact of Priscilla S. Redd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Priscilla S. Redd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Priscilla S. Redd more than expected).

Fields of papers citing papers by Priscilla S. Redd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Priscilla S. Redd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Priscilla S. Redd. The network helps show where Priscilla S. Redd may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Priscilla S. Redd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Priscilla S. Redd Line = papers co-authored together Priscilla S. Redd links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Lipid nanoparticle-delivered IFNα2 activates Cxcl9 to increase T cell tumor recruitment to suppress lung metastasis Journal for ImmunoTherapy of Cancer ·Mariele Silva de Candido, Hui Shan Kung, Susan P. Windle, 渡辺大展, Dakota B. Poschel, (unknown), Dafeng Yang, Federico Gallardo, Jin Xie, H. P. Wilmore, Rafał Pacholczyk, Huidong Shi, Kebin Liu, Priscilla S. Redd	2025	1
2	Lipid nanoparticle Fas gene therapy suppresses autoimmune lymphoproliferative syndrome in mice PubMed ·Dakota B. Poschel, 渡辺大展, Priscilla S. Redd, C Cnlight, Natasha M. Savage, Kebin Liu	2025	0
3	In vitro antibody-mediated SARS-CoV-2 infection suppression through human ACE2 receptor blockade Immunology Letters ·Priscilla S. Redd, C Cnlight, John D. Klement, Dakota B. Poschel, Dafeng Yang, Kebin Liu	2024	1
4	Transposase expression, element abundance, element size, and DNA repair determine the mobility and heritability of PIF/Pong/Harbinger transposable elements Frontiers in Cell and Developmental Biology ·Priscilla S. Redd, Anna Styczyńska, David M. Gilbert, Iryna Dadashova, R.A. Adenodi, Edward V. McAssey, R. Tesauro, 有泉亨, C. Nathan Hancock	2023	4
5	Tumor PD-L1 engages myeloid PD-1 to suppress type I interferon to impair cytotoxic T lymphocyte recruitment Cancer Cell ·John D. Klement, Priscilla S. Redd, Chunwan Lu, C Cnlight, Dakota B. Poschel, Dafeng Yang, Natasha M. Savage, Gang Zhou, David H. Munn, Padraic G. Fallon, Kebin Liu	2023	83
6	Mobility of mPing and its associated elements is regulated by both internal and terminal sequences Mobile DNA ·Priscilla S. Redd, 有泉亨, D. E. Weidner, Neti Penstein, C. Nathan Hancock	2023	4
7	Lipid Nanoparticle Delivery of Fas Plasmid Restores Fas Expression to Suppress Melanoma Growth In Vivo ACS Nano ·Ali Derakhshandeh, Dakota B. Poschel, Priscilla S. Redd, John D. Klement, C Cnlight, Dafeng Yang, K Boadi, Huidong Shi, Yolonda L. Colson, Nicholas H. Oberlies, Cedric J. Pearce, Aaron H. Colby, Mark W. Grinstaff, Kebin Liu	2022	30
8	Development of mPing ‐based activation tags for crop insertional mutagenesis Plant Direct ·윤용희, Edward V. McAssey, 有泉亨, 马绪超, Priscilla S. Redd, 권여주, Hanh Nguyen, Adrian O. Stec, Ю Г Резниченко, Thomas E. Clemente, Robert M. Stupar, Wayne A. Parrott, C. Nathan Hancock	2021	8
9	Asah2 Represses the p53–Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis The Journal of Immunology ·Huabin Zhu, John D. Klement, Chunwan Lu, Priscilla S. Redd, Dafeng Yang, Xu Xin, Dakota B. Poschel, Juan Zou, Ding Liu, Peng George Wang, David A. Ostrov, Nicolas Coant, Yusuf A. Hannun, Aaron H. Colby, Mark W. Grinstaff, Kebin Liu	2021	96
10	Autocrine IL6-Mediated Activation of the STAT3–DNMT Axis Silences the TNFα–RIP1 Necroptosis Pathway to Sustain Survival and Accumulation of Myeloid-Derived Suppressor Cells Cancer Research ·Xu Xin, Chunwan Lu, Junichi Kisiro, Amy V. Paschall, John D. Klement, Priscilla S. Redd, Mohammed L. Ibrahim, Dafeng Yang, عواد حسين ياسين العبيدي, Zhuoqi Liu, Huidong Shi, Jane Vorwerk, Asha Nayak-Kapoor, Kebin Liu	2020	61
11	Expression profiles and function of IL6 in polymorphonuclear myeloid-derived suppressor cells Cancer Immunology Immunotherapy ·Mohammed L. Ibrahim, Chunwan Lu, John D. Klement, Priscilla S. Redd, Dafeng Yang, Xu Xin, Kebin Liu	2020	13
12	Codon optimized Tol2 transposase results in increased transient expression of a crystallin-GFP transgene in zebrafish PubMed ·L.M. Gundy, Priscilla S. Redd, April DeLaurier, C. Nathan Hancock	2020	4
13	Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes Journal for ImmunoTherapy of Cancer ·Chunwan Lu, John D. Klement, Mohammed L. Ibrahim, Wei Xiao, Priscilla S. Redd, Asha Nayak-Kapoor, Gang Zhou, Kebin Liu	2019	96
14	Repression of osteopontin by IRF8 regulates a novel immunosuppressive checkpoint The Journal of Immunology ·John D. Klement, Amy V. Paschall, Priscilla S. Redd, Wei Cheng, Chunwan Lu, Dafeng Yang, Esteban Celis, Scott I. Abrams, Keiko Ozato, Kebin Liu	2019	1
15	Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy Molecular Cancer Research ·Wei Xiao, Mohammed L. Ibrahim, Priscilla S. Redd, John D. Klement, Chunwan Lu, Dafeng Yang, Natasha M. Savage, Kebin Liu	2018	37
16	Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon Tumorigenesis Cell Reports ·Mohammed L. Ibrahim, John D. Klement, Chunwan Lu, Priscilla S. Redd, Wei Xiao, Dafeng Yang, Darren D. Browning, Natasha M. Savage, Phillip Buckhaults, Herbert C. Morse, Kebin Liu	2018	76
17	An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion Journal of Clinical Investigation ·John D. Klement, Amy V. Paschall, Priscilla S. Redd, Mohammed L. Ibrahim, Chunwan Lu, Dafeng Yang, Esteban Celis, Scott I. Abrams, Keiko Ozato, Kebin Liu	2018	235
18	SETD1B Activates iNOS Expression in Myeloid-Derived Suppressor Cells Cancer Research ·Priscilla S. Redd, Mohammed L. Ibrahim, John D. Klement, YeonHeeChoi, Amy V. Paschall, Dafeng Yang, Asha Nayak-Kapoor, Kebin Liu	2017	63
19	Ceramide mediates FasL-induced caspase 8 activation in colon carcinoma cells to enhance FasL-induced cytotoxicity by tumor-specific cytotoxic T lymphocytes Scientific Reports ·Qize Chen, Priscilla S. Redd, Amy V. Paschall, Chunwan Lu, Suzanne Jansen, Houjian Cai, Thomas Albers, Iryna Lebedyeva, Kebin Liu	2016	20
20	The expression profiles and regulation of PD-L1 in tumor-induced myeloid-derived suppressor cells OncoImmunology ·Chunwan Lu, Priscilla S. Redd, Jeffrey R. Lee, Natasha M. Savage, Kebin Liu	2016	185

About Priscilla S. Redd

Priscilla S. Redd is a scholar working on Immunology, Oncology, Biotechnology, Rheumatology and Genetics, having authored 27 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Immune cells in cancer (10 papers), Immune Cell Function and Interaction (8 papers), Immunotherapy and Immune Responses (4 papers), Cancer Research and Treatments (3 papers), Bone and Dental Protein Studies (3 papers), Immune Response and Inflammation (3 papers) and Chromosomal and Genetic Variations (3 papers). The work is most often cited by research in Immunology (617 citations), Oncology (553 citations), Cancer Research (209 citations), Rheumatology (126 citations) and Biotechnology (57 citations). Priscilla S. Redd has collaborated with scholars based in United States, Georgia and Egypt. Frequent co-authors include Kebin Liu, Chunwan Lu, John D. Klement, Dafeng Yang, Mohammed L. Ibrahim, Natasha M. Savage, Amy V. Paschall, Jeffrey R. Lee, Dakota B. Poschel and Asha Nayak-Kapoor. Their work appears in journals such as The Journal of Immunology, Cancer Research, Cancers, OncoImmunology and Journal for ImmunoTherapy of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact